Search

Hydrochlorothiazide

[L7426,L7459] Hydrochlorothiazide was granted FDA approval on 12 February 1959.[L8444]

Racepinephrine

Racepinephrine is a racemic mixture consisting of d-DB00668 and l-DB00668 enantiomers. Epinephrine is a non-selective α- and β-adrenergic receptor agonist. It is a bronchodilator used in the temporary relief of mild symptoms of intermitt...

Besifloxacin

FDA approved on May 28, 2009.

Chromous sulfate

Alirocumab

From this family, it was the first agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. … Alirocumab is a biopharmaceutical that obtained FDA approval in July 2015 as a second line treatment for high cholesterol in adults whose LDL-cholesterol (LDL-C) is not controlled by the combination of

Atezolizumab

[L7489] Atezolizumab was granted FDA approval on 18 October 2016.

Potassium bicarbonate

[T141] It is registered in the FDA under the section of suitable, safe and effective ingredients for OTC antacids.[L1836] This FDA denomination classifies potassium bicarbonate as a GRAS ingredient.

Ferric carboxymaltose

It was FDA approved on July 25, 2013.

Chromium gluconate

Chromium nicotinate